Login / Signup

Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis.

Inbeom KwonNayeon ChoiJi Hui ShinSeunghun LeeBora NamTae Hwan Kim
Published in: Journal of rheumatic diseases (2023)
In AS patients, anti-TNF treatment has been found to increase lipid particles, potentially due to its anti-inflammatory effects. Future research should explore the underlying mechanism and the clinical implications of dyslipidemia, particularly the occurrence of cardiovascular events, following anti-TNF treatment in AS patients.
Keyphrases
  • cardiovascular events
  • rheumatoid arthritis
  • ankylosing spondylitis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • coronary artery disease
  • cardiovascular disease
  • current status
  • patient reported